The novel δ opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats without producing the adverse effects associated with benzodiazepines

Akiyoshi Saitoh, Azusa Sugiyama, Misa Yamada, Masatoshi Inagaki, Jun Ichiro Oka, Hiroshi Nagase, Mitsuhiko Yamada

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

We previously reported that a δ opioid receptor agonist SNC80 produced potent anxiolytic-like effects in rodents. Recently, we succeeded in synthesizing a novel δ opioid receptor agonist KNT-127. In this study, we investigated the anxiolytic-like effects of KNT-127 using three different rat models of innate anxiety. In an elevated plus-maze test, KNT-127 (0.3, 1, and 3.0 mg/kg, s.c.) significantly and dose-dependently increased the time rats spent in the open arms 30 min after administration. The magnitude of the KNT-127 (3.0 mg/kg, s.c.)-induced anxiolytic-like effects was similar to that produced by diazepam (1.0 mg/kg, s.c.), a benzodiazepine anxiolytic. The anxiolytic-like effects of KNT-127 (3.0 mg/kg, s.c.) were abolished by pretreatment with naltrindole (0.1 mg/kg, s.c.), a selective δ opioid receptor antagonist, suggesting that KNT-127-induced anxiolytic-like effects are mediated by δ opioid receptors. These findings were supported by results obtained from light/dark and open-field tests. Interestingly, in contrast to diazepam (1.0 mg/kg, s.c.), KNT-127 (3.0 mg/kg, s.c.) caused no significant performance changes in the Y-maze test, the ethanol-induced sleeping test, and footprint test. This is the first study to demonstrate that the novel δ opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats, without producing the adverse effects associated with benzodiazepines.

Original languageEnglish
Pages (from-to)485-493
Number of pages9
JournalNeuropharmacology
Volume67
DOIs
Publication statusPublished - Apr 2013
Externally publishedYes

Fingerprint

Anti-Anxiety Agents
Opioid Receptors
Benzodiazepines
naltrindole
Diazepam
Narcotic Antagonists
KNT 127
Rodentia
Ethanol
Anxiety
Light

Keywords

  • Animal model
  • GABA-benzodiazepine receptor
  • Innate anxiety

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

The novel δ opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats without producing the adverse effects associated with benzodiazepines. / Saitoh, Akiyoshi; Sugiyama, Azusa; Yamada, Misa; Inagaki, Masatoshi; Oka, Jun Ichiro; Nagase, Hiroshi; Yamada, Mitsuhiko.

In: Neuropharmacology, Vol. 67, 04.2013, p. 485-493.

Research output: Contribution to journalArticle

Saitoh, Akiyoshi ; Sugiyama, Azusa ; Yamada, Misa ; Inagaki, Masatoshi ; Oka, Jun Ichiro ; Nagase, Hiroshi ; Yamada, Mitsuhiko. / The novel δ opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats without producing the adverse effects associated with benzodiazepines. In: Neuropharmacology. 2013 ; Vol. 67. pp. 485-493.
@article{7217a69dd5394e56ba1b343e29b2477c,
title = "The novel δ opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats without producing the adverse effects associated with benzodiazepines",
abstract = "We previously reported that a δ opioid receptor agonist SNC80 produced potent anxiolytic-like effects in rodents. Recently, we succeeded in synthesizing a novel δ opioid receptor agonist KNT-127. In this study, we investigated the anxiolytic-like effects of KNT-127 using three different rat models of innate anxiety. In an elevated plus-maze test, KNT-127 (0.3, 1, and 3.0 mg/kg, s.c.) significantly and dose-dependently increased the time rats spent in the open arms 30 min after administration. The magnitude of the KNT-127 (3.0 mg/kg, s.c.)-induced anxiolytic-like effects was similar to that produced by diazepam (1.0 mg/kg, s.c.), a benzodiazepine anxiolytic. The anxiolytic-like effects of KNT-127 (3.0 mg/kg, s.c.) were abolished by pretreatment with naltrindole (0.1 mg/kg, s.c.), a selective δ opioid receptor antagonist, suggesting that KNT-127-induced anxiolytic-like effects are mediated by δ opioid receptors. These findings were supported by results obtained from light/dark and open-field tests. Interestingly, in contrast to diazepam (1.0 mg/kg, s.c.), KNT-127 (3.0 mg/kg, s.c.) caused no significant performance changes in the Y-maze test, the ethanol-induced sleeping test, and footprint test. This is the first study to demonstrate that the novel δ opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats, without producing the adverse effects associated with benzodiazepines.",
keywords = "Animal model, GABA-benzodiazepine receptor, Innate anxiety",
author = "Akiyoshi Saitoh and Azusa Sugiyama and Misa Yamada and Masatoshi Inagaki and Oka, {Jun Ichiro} and Hiroshi Nagase and Mitsuhiko Yamada",
year = "2013",
month = "4",
doi = "10.1016/j.neuropharm.2012.11.025",
language = "English",
volume = "67",
pages = "485--493",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - The novel δ opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats without producing the adverse effects associated with benzodiazepines

AU - Saitoh, Akiyoshi

AU - Sugiyama, Azusa

AU - Yamada, Misa

AU - Inagaki, Masatoshi

AU - Oka, Jun Ichiro

AU - Nagase, Hiroshi

AU - Yamada, Mitsuhiko

PY - 2013/4

Y1 - 2013/4

N2 - We previously reported that a δ opioid receptor agonist SNC80 produced potent anxiolytic-like effects in rodents. Recently, we succeeded in synthesizing a novel δ opioid receptor agonist KNT-127. In this study, we investigated the anxiolytic-like effects of KNT-127 using three different rat models of innate anxiety. In an elevated plus-maze test, KNT-127 (0.3, 1, and 3.0 mg/kg, s.c.) significantly and dose-dependently increased the time rats spent in the open arms 30 min after administration. The magnitude of the KNT-127 (3.0 mg/kg, s.c.)-induced anxiolytic-like effects was similar to that produced by diazepam (1.0 mg/kg, s.c.), a benzodiazepine anxiolytic. The anxiolytic-like effects of KNT-127 (3.0 mg/kg, s.c.) were abolished by pretreatment with naltrindole (0.1 mg/kg, s.c.), a selective δ opioid receptor antagonist, suggesting that KNT-127-induced anxiolytic-like effects are mediated by δ opioid receptors. These findings were supported by results obtained from light/dark and open-field tests. Interestingly, in contrast to diazepam (1.0 mg/kg, s.c.), KNT-127 (3.0 mg/kg, s.c.) caused no significant performance changes in the Y-maze test, the ethanol-induced sleeping test, and footprint test. This is the first study to demonstrate that the novel δ opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats, without producing the adverse effects associated with benzodiazepines.

AB - We previously reported that a δ opioid receptor agonist SNC80 produced potent anxiolytic-like effects in rodents. Recently, we succeeded in synthesizing a novel δ opioid receptor agonist KNT-127. In this study, we investigated the anxiolytic-like effects of KNT-127 using three different rat models of innate anxiety. In an elevated plus-maze test, KNT-127 (0.3, 1, and 3.0 mg/kg, s.c.) significantly and dose-dependently increased the time rats spent in the open arms 30 min after administration. The magnitude of the KNT-127 (3.0 mg/kg, s.c.)-induced anxiolytic-like effects was similar to that produced by diazepam (1.0 mg/kg, s.c.), a benzodiazepine anxiolytic. The anxiolytic-like effects of KNT-127 (3.0 mg/kg, s.c.) were abolished by pretreatment with naltrindole (0.1 mg/kg, s.c.), a selective δ opioid receptor antagonist, suggesting that KNT-127-induced anxiolytic-like effects are mediated by δ opioid receptors. These findings were supported by results obtained from light/dark and open-field tests. Interestingly, in contrast to diazepam (1.0 mg/kg, s.c.), KNT-127 (3.0 mg/kg, s.c.) caused no significant performance changes in the Y-maze test, the ethanol-induced sleeping test, and footprint test. This is the first study to demonstrate that the novel δ opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats, without producing the adverse effects associated with benzodiazepines.

KW - Animal model

KW - GABA-benzodiazepine receptor

KW - Innate anxiety

UR - http://www.scopus.com/inward/record.url?scp=84873368318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873368318&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2012.11.025

DO - 10.1016/j.neuropharm.2012.11.025

M3 - Article

C2 - 23246531

AN - SCOPUS:84873368318

VL - 67

SP - 485

EP - 493

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

ER -